2-piperidone has been researched along with Thyroid Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboussekhra, A; Al-Jammaz, I; Al-Mohanna, F; Al-Mohanna, M; Al-Otaibi, B; Alhabardi, SA; Alraouji, NN | 1 |
| Choi, MG; Ihm, SH; Kang, JG; Kim, CS; Kim, SH; Lee, SJ; Yoo, HJ | 3 |
| Barollo, S; Bertazza, L; Casal Ide, E; Cavedon, E; Censi, S; Iacobone, M; Manso, J; Mian, C; Pezzani, R; Sensi, F; Vianello, F; Watutantrige-Fernando, S | 1 |
5 other study(ies) available for 2-piperidone and Thyroid Neoplasms
| Article | Year |
|---|---|
The curcumin analogue PAC has potent anti-anaplastic thyroid cancer effects.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Curcumin; Humans; Mice; Piperidones; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; TOR Serine-Threonine Kinases | 2023 |
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Flow Cytometry; Humans; Isoxazoles; Piperidones; Pyrimidines; Resorcinols; Signal Transduction; Thyroid Neoplasms | 2017 |
Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.
Topics: Apoptosis; Biomarkers, Tumor; Cell Survival; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Piperidones; Pyrimidines; Signal Transduction; Sulfonamides; Thyroid Neoplasms; Tumor Cells, Cultured | 2018 |
Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
Topics: AMP-Activated Protein Kinases; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hypoglycemic Agents; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Potential, Mitochondrial; Metformin; Phosphorylation; Piperidones; Pyrimidines; Signal Transduction; Thyroid Neoplasms; Vascular Cell Adhesion Molecule-1 | 2018 |
EF24 (a Curcumin Analog) and ZSTK474 Emphasize the Effect of Cabozantinib in Medullary Thyroid Cancer.
Topics: Aged; Anilides; Antineoplastic Agents; Benzylidene Compounds; Carcinoma, Neuroendocrine; Cell Proliferation; Drug Synergism; Female; Humans; Male; Middle Aged; Piperidones; Pyridines; Thyroid Neoplasms; Triazines; Tumor Cells, Cultured | 2018 |